All India Institute of Medical Sciences, New Delhi, is a public medical research university and hospital in New Delhi, India. The institute is governed by the AIIMS Act, 1956 and operates autonomously under the Ministry of Health and Family Welfare.
The Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) is a medical school located in Pondicherry, India. JIPMER is an Institute of National Importance (INI) and a tertiary care referral hospital. It is under the direct administrative control of the Ministry of Health and Family Welfare, and Government of India, with autonomy to run its internal administration.
The Tata Memorial Hospital (TMH) situated in Parel, Mumbai, is a cancer institute. It is an autonomous institution under the administrative control of Department of Atomic Energy, Government of India. Its current Director is Dr. Sudeep Gupta.
M. Krishnan Nair was an Indian oncologist. He was the founding director of the Regional Cancer Centre, Thiruvananthapuram, a director of the S.U.T. Institute of Oncology, and Trivandrum Cancer Center(TCC), part of SUT Royal Hospital in Thiruvananthapuram (Trivandrum) and a professor at the Amrita Institute of Medical Sciences & Research in Kochi. The Government of India awarded him the fourth highest civilian award of the Padma Shri in 2001 for his contributions in the cancer care field.
Safdarjung Hospital is a multi-specialty hospital, and the largest central government hospital in India if measured by bed strength. It is associated with Vardhman Mahavir Medical College and located in the heart of New Delhi on the Ring Road, opposite to the All India Institute of Medical Sciences (AIIMS).
Josep Baselga i Torres, known in Spanish as José Baselga, was a Spanish medical oncologist and researcher focused on the development of novel molecular targeted agents, with a special emphasis in breast cancer. Through his career he was associated with the Memorial Sloan Kettering Cancer Center, Vall d'Hebron Institute of Oncology, and the Massachusetts General Hospital in their hematology and oncology divisions. He led the development of the breast cancer treatment Herceptin, a monoclonal antibody, that targets the HER2 protein, which is impacted in aggressive breast cancers.
Martine J. Piccart-Gebhart is a Belgian medical oncologist. She is a professor of oncology at the Université Libre de Bruxelles and scientific director at the Jules Bordet Institute in Brussels, Belgium. She is also a member of the Belgian Royal Academy of Medicine.
Ketayun Ardeshir Dinshaw FRCR was a prominent personality in the field of Indian medicine and played a significant role in the evolution of modern cancer care in India, and the development of effective radiation therapy. In 2001, the President of India conferred on her the Padma Shri. A prominent news channel has described her as: “The ultimate hope and the last possible post to cling onto for the cancer-struck in India”. Over a thirty-year period, Dinshaw revolutionised cancer medicine in India, refining multi-modal treatments as the exception rather than the rule.
Dr. Kodaganur S. Gopinath, MS, FAMS, FRCS (Edin) is an Indian surgical oncologist, known for his pioneering work on oncological research. He is a recipient of many awards including Dr. B. C. Roy Award, considered to be the premier medical honour in the country. The President of India recognised his services to the field of oncology, by awarding him the fourth highest civilian award, Padma Shri, in 2010.
Rajendra Achyut Badwe, is an Indian medical doctor and surgical oncologist. He was honoured by the Government of India, in 2013, by bestowing on him the Padma Shri, the fourth highest civilian award, for his contributions to the field of medicine. He is the former Director of Tata Memorial Centre, succeeded by Sudeep Gupta
Pramod Kumar Julka, is an Indian cancer specialist (oncologist), medical educationist and writer, known for performing the first peripheral blood stem cell transplant following high dose chemotherapy in Metastatic Breast Cancer in India. He was honoured by the Government of India, in 2013, by bestowing on him the Padma Shri, the fourth highest civilian award, for his contributions to the fields of medicine and medical education. The American Society of Clinical Oncology (ASCO) has awarded him by bestowing on him the honorary membership.
Lalit Kumar is an Indian oncologist, known to have contributed to the development of low cost medical facilities in Delhi. The Government of India honoured him, in 2014, with the award of Padma Shri, the fourth highest civilian award, for his contributions to the fields of medicine.
Dr. Jitendra Kumar Singh is an Indian oncologist, the ex director of Mahavir Cancer Institute & Research Centre and the president of Cancer Care India, the apex body for cancer support organisations in India. He was honoured by the Government of India, in 2012, with the fourth highest Indian civilian award of Padma Shri.
Ashok K. Vaid is an Indian medical oncologist, who specializes in bone marrow transplantation. He is credited with the performance of the first 25 bone marrow transplantations in the private sector in North India. He heads the Cancer Institute- Division of Medical Oncology and Haemotology at Medanta The Medicity.
Darab Jehangir Jussawala (1915–1999) was an Indian medical-cum-surgical oncologist, medical writer and the director of Tata Memorial Centre. He was the co-founder of Indian Cancer Society, along with Naval Tata in 1951, and the founder of the Indian Cancer Rehabilitation Centre in Parel, Mumbai, in 1956, the first such centre in India and the largest in Asia. He served as the director of Lady Ratan Tata Medical and Research Center and as the honorary consultant at two Mumbai hospitals, Breach Candy Hospital and Jaslok Hospital. An elected fellow of the Royal Society of Medicine, National Academy of Medical Sciences, Indian Academy of Sciences, Indian National Science Academy and the American College of Surgeons, he was a recipient of the Dhanwantari Award as well as several Oration Awards. The Government of India awarded him the third highest civilian honour of the Padma Bhushan, in 1975, for his contributions to Medicine.
Prafulla B. Ragubhai Desai is an Indian surgical oncologist and a former chairman of the Research Advisory Committee on Oncology of the Indian Council of Medical Research. He is credited with the first bone marrow transplantation in India, which he performed with his team in 1983. He is a former director and superintendent at Tata Memorial Centre, Mumbai (1973–1995) and continues his association with the institution as their professor emeritus. He is one of the founders of the Rural Cancer Centre established by Tata Memorial Centre at Barshi, Mumbai and serves Breach Candy Hospital as a surgical oncologist and the Indo-Global Summit on Head and Neck Oncology (IGSHNO) as a member of their national faculty.
Amit Dutt is an Indian scientist, geneticist and the principal investigator at Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) of Tata Memorial Centre. Known for his studies on Fibroblast growth factor receptor, Dutt is a Wellcome Trust / DBT India Alliance Intermediate Fellow. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, for his contributions to medical sciences in 2017.
Indraneel Mittra FRCS (England), FASc, FNA is an Indian cancer surgeon, basic research scientist, and public health researcher. He is the Dr. Ernest Borges Chair in Translational Research and Professor Emeritus in the Department of Surgical Oncology, Tata Memorial Centre (TMC) in Mumbai. He established the first dedicated multi-disciplinary Breast Unit in India – a model which has since been adopted by most centers in the country. He pioneered the discipline of clinical research in cancer in India and pursued the cause of improving cancer care in the developing world. In this context, and with an RO1 grant from the National Institutes of Health (NIH) of the United States, Mittra spearheaded one of the largest randomized trials of screening for early detection of breast and cervical cancer using low-cost technology approaches involving 150,000 women in the suburbs of Mumbai. He is the first Indian recipient of such a competitive grant from the NIH. In the field of laboratory research, he is credited with having discovered the wide-ranging biological activities of cell-free chromatin particles (cfChPs), which have critical implications for human health and disease, and how deactivating cfChPs can have many therapeutic effects. Prof. Mittra’s current research interests revolve around studying cfChPs in the context of evolution.
Tata Medical Center (TMC) is a medical center or hospital located on New Town in Kolkata Metropolitan Area, West Bengal. It is one of the 62 specialist cancer treatment and research centres in India. In 2011, the hospital started operations with 160 beds.
Susana Banerjee is an English oncologist who is Research Lead within the Gynaecology Unit at London's The Royal Marsden. She is Professor in Women's Cancers and Team Leader at the Institute of Cancer Research.
